In a world where precision medicine is becoming the gold standard, bispecific antibodies are fast emerging as a game-changing innovation in the pharmaceutical landscape. These engineered proteins are designed to bind to two different antigens at the same time—offering an incredibly targeted approach to treating cancer, autoimmune diseases, and infectious conditions. With the...